+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

3D Printed Drugs Market Research Report by Technology, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5121795
  • Report
  • September 2021
  • Region: United States
  • 84 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States 3D Printed Drugs Market Will Grow to USD 71.13 Million by 2026, at a CAGR of 11.24%
The United States 3D Printed Drugs Market size was estimated at USD 37.52 Million in 2020 and expected to reach USD 41.94 Million in 2021, at a Compound Annual Growth Rate (CAGR) 11.24% to reach USD 71.13 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the 3D Printed Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the 3D Printed Drugs Market was studied across Direct-Write, Fused Deposition Modelling, Inkjet Printing, Powder Bed Printing, Stereolithography, and Zip Dose.
  • Based on End User, the 3D Printed Drugs Market was studied across Clinics & Hospitals and Research Laboratories.
  • Based on State, the 3D Printed Drugs Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the 3D Printed Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States 3D Printed Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States 3D Printed Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States 3D Printed Drugs Market?
4. What is the competitive strategic window for opportunities in the United States 3D Printed Drugs Market?
5. What are the technology trends and regulatory frameworks in the United States 3D Printed Drugs Market?
6. What is the market share of the leading vendors in the United States 3D Printed Drugs Market?
7. What modes and strategic moves are considered suitable for entering the United States 3D Printed Drugs Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Technology Outlook
3.4. End User Outlook
3.5. State Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. 3D Printed Drugs Market, by Technology
6.1. Introduction
6.2. Direct-Write
6.3. Fused Deposition Modelling
6.4. Inkjet Printing
6.5. Powder Bed Printing
6.6. Stereolithography
6.7. Zip Dose

7. 3D Printed Drugs Market, by End User
7.1. Introduction
7.2. Clinics & Hospitals
7.3. Research Laboratories

8. California 3D Printed Drugs Market
8.1. Introduction

9. Florida 3D Printed Drugs Market
9.1. Introduction

10. Illinois 3D Printed Drugs Market
10.1. Introduction

11. New York 3D Printed Drugs Market
11.1. Introduction

12. Ohio 3D Printed Drugs Market
12.1. Introduction

13. Pennsylvania 3D Printed Drugs Market
13.1. Introduction

14. Texas 3D Printed Drugs Market
14.1. Introduction

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
FIGURE 3. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 4. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 5. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 6. UNITED STATES 3D PRINTED DRUGS MARKET: MARKET DYNAMICS
FIGURE 7. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 8. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 10. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, 2018-2026 (USD MILLION)
FIGURE 11. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 12. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, 2018-2026 (USD MILLION)
FIGURE 13. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 14. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2026 (USD MILLION)
FIGURE 15. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 16. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 23. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2026
FIGURE 25. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. CALIFORNIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. FLORIDA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. ILLINOIS 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. NEW YORK 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. OHIO 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. PENNSYLVANIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. TEXAS 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES 3D PRINTED DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 37. UNITED STATES 3D PRINTED DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 38. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES 3D PRINTED DRUGS MARKET, BY TYPE

List of Tables
TABLE 1. UNITED STATES 3D PRINTED DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. CALIFORNIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 15. FLORIDA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. ILLINOIS 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. NEW YORK 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. OHIO 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. PENNSYLVANIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. TEXAS 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES 3D PRINTED DRUGS MARKET: SCORES
TABLE 22. UNITED STATES 3D PRINTED DRUGS MARKET: BUSINESS STRATEGY
TABLE 23. UNITED STATES 3D PRINTED DRUGS MARKET: PRODUCT SATISFACTION
TABLE 24. UNITED STATES 3D PRINTED DRUGS MARKET: RANKING
TABLE 25. UNITED STATES 3D PRINTED DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 26. UNITED STATES 3D PRINTED DRUGS MARKET: MERGER & ACQUISITION
TABLE 27. UNITED STATES 3D PRINTED DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 28. UNITED STATES 3D PRINTED DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 29. UNITED STATES 3D PRINTED DRUGS MARKET: INVESTMENT & FUNDING
TABLE 30. UNITED STATES 3D PRINTED DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 31. UNITED STATES 3D PRINTED DRUGS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll